(Q35076575)

6 August 2017

1 reference

title

The cost of adverse drug reactions. (English)

1 reference

6 August 2017

Sophie Gautier

1

1 reference

6 August 2017

Hélène Bachelet

series ordinal

2

1 reference

6 August 2017

Régis Bordet

series ordinal

3

1 reference

6 August 2017

Jacques Caron

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Expert Opinion on Pharmacotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

319-326

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

6 August 2017

1 reference

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

Frequency and cost of serious adverse drug reactions in a department of general medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

Incidence and cost of adverse drug reactions in a French cancer institute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

Counting the costs of drug-related adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

Hospital characteristics associated with adverse events and substandard care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

Methods and systems to detect adverse drug reactions in hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

Adverse drug reactions: definitions, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

Economic aspects of antibacterial adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.319

21 January 2018

Identifiers

DOI

10.1517/14656566.4.3.319

1 reference

6 August 2017

1 reference